Patients are unwilling to enter clinical trials

BMJ 1994; 309 doi: https://doi.org/10.1136/bmj.309.6953.539b (Published 20 August 1994) Cite this as: BMJ 1994;309:539
  1. F Macbeth
  1. Christchurch Hospital, Christchurch, New Zealand.

    EDITOR, - T C B Dehn is right to draw attention to the problems of obtaining informed consent from patients entering randomised trials, particularly when one option entails additional, potentially toxic treatment, such as chemotherapy.1 But Dehn's letter also illustrates the problem of avoiding bias when describing a trial: Dehn admits …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription